You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Inhibitors-RI173
RI173

Chemical Structure : RI173

CAS No.: 729-46-4

RI173 (JX06)

Catalog No.: PC-47067Not For Human Use, Lab Use Only.

RI173 is a potent, covalent, triple-acting inhibitor of SARS-CoV-2 protease Mpro, PLpro and human cathepsin L with IC50 of 0.6 uM, 0.2 uM and 1.7 uM, respectively.

Packing Price Stock Quantity
25 mg $198 In stock
50 mg $348 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

RI173 is a potent, covalent, triple-acting inhibitor of SARS-CoV-2 protease Mpro, PLpro and human cathepsin L with IC50 of 0.6 uM, 0.2 uM and 1.7 uM, respectively.
RI173 covalently reacts to the active cysteine residue of SARS-CoV-2 Mpro (Cys 145) and Plpro (Cys111), exhibits 10-fold more potent than disulfiram against SARS-CoV-2 protease.
RI173 exhibits antiviral activity in a narrow range from approximately 100 to 200 nM in SARS-CoV-2 infectivity cells-based assays。
RI173 also shows greater antiviral effect and less toxicitythan disulfiram.

Physicochemical Properties

M.Wt 324.490
Formula C10H16N2O2S4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

morpholine-4-carbothioic dithioperoxyanhydride

References

1. Meewan I, et al. Pharmaceuticals (Basel). 2022 Jun 13;15(6):744.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: